Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOVASTATIN vs LUCENTIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOVASTATIN vs LUCENTIS: Safety Overview

Metric LOVASTATIN LUCENTIS
Total FAERS Reports 1,387 686
Deaths Reported 204 184
Death Rate 14.7% 26.8%
Hospitalizations 287 180
Average Patient Age 60.2 yrs 71.6 yrs
% Female Patients 55.9% N/A
FDA Approval Date Apr 14, 2006 N/A
Manufacturer Preferred Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A